PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability-Reference-Cited by-同舟云学术

PEGylated E. coli asparaginase desensitization: an effective and feasible option for pediatric patients with acute lymphoblastic leukemia who have developed hypersensitivity to pegaspargase in the absence of asparaginase Erwinia chrysanthemi availability

Published:2019-07-04 Issue:5 Volume:36 Page:277-286
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Verma Anupam¹,Chen Karin²,Bender Cynthia³,Gorney Nathan³,Leonard Whitney³,Barnette Phillip¹

Affiliation:

1. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, School of Medicine, Salt Lake City, Utah, USA;

2. Department of Pediatrics, Division of Allergy & Immunology, University of Utah, School of Medicine, Salt Lake City, Utah, USA;

3. Department of Pharmacy, Primary Children’s Hospital, Salt Lake City, Utah, USA

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2019.1634778

Reference29 articles.

1. Biology and Treatment of Acute Lymphoblastic Leukemia

2. Childhood relapsed acute lymphoblastic leukemia: Biology and recent treatment progress

3. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia

4. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

5. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple reactions during desensitization and predicting decreased efficacy of pegaspargase chemotherapy;Annals of Allergy, Asthma & Immunology;2024-08

2. Rapid Drug Desensitization and Management of Breakthrough Reactions in Pediatric Patients;ASTHMA ALLERGY IMMUN;2024

3. Predictive factors for l-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia;International Journal of Hematology;2024-02-29

4. Desensitization using pegaspargase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization;Pediatric Blood & Cancer;2024-02-04

5. Attempted desensitization to calaspargase pegol: a familiar approach to a new problem;Leukemia & Lymphoma;2023-11-22